SME Central
Home / Moved to Main Board / Vaishali Pharma

Vaishali Pharma: IPO, Share Price and Results Since Listing

Vaishali Pharma moved from NSE Emerge to the NSE main board on 15 January 2020. For Q2 FY2027 it reported revenue of INR 30.17 crore (-9.80% on a year earlier) and a profit after tax of INR 2.06 crore.

Key Facts

Moved to
NSE main board on 15 January 2020
Symbol
VAISHALI
Latest close
INR 7.02 on 16 November 2026

Results Filed With NSE

Consolidated figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202730.17-9.80%2.060.16main board14 November 2026
Q1 FY202722.89–1.550.12main board14 August 2026
Q4 FY202626.93–0.380.03main board30 June 2026
FY2026108.77–4.160.32main board30 June 2026
Q3 FY202624.65–1.320.10main board13 February 2026
Q2 FY202633.45–1.190.09main board14 November 2025

Promoter Holding

Promoter holding has moved from 56.31% on 30 September 2021 to 31.61% on 30 September 2026 (-24.70 percentage points).

As ofPromotersPublic
30 September 202631.61%68.39%
3 July 202630.54%69.46%
30 June 202631.61%68.39%
31 March 202631.61%68.39%
31 December 202531.61%68.39%
24 December 202531.61%68.39%
30 September 202526.32%73.68%
30 June 202526.32%73.68%
31 March 202526.32%73.68%
31 December 202426.32%73.68%
30 September 202426.32%73.68%
16 July 202431.61%68.39%
30 June 202426.32%73.68%
17 May 202424.87%75.13%
13 May 202425.77%74.23%
31 March 202426.32%73.68%
31 December 202326.62%73.38%
30 September 202326.62%73.38%
30 June 202326.74%73.26%
31 March 202326.74%73.26%
31 December 202226.74%73.24%
30 September 202226.74%73.26%
30 June 202226.74%73.26%
31 March 202226.74%73.25%
31 December 202156.31%43.69%
30 September 202156.31%43.69%

Sources: NSE filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.